Importantly, high levels of FGF21 have been associated with different metabolic diseases, such as obesity [47], T2DM [48], non-alcoholic steatohepatitis (NASH) [49], cardiometabolic disorders [50], and congenital or acquired lipodystrophy [51,52]. This evidence concerns the gene FGF21 and metabolic disease.